|
1
|
Reimer-Michalski EM and Conrath U: Innate
immune memory in plants. Semin Immunol. 28:319–327. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Netea MG, Quintin J and van der Meer JW:
Trained immunity: A memory for innate host defense. Cell Host
Microbe. 9:355–361. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rosing MT: 13C-Depleted carbon
microparticles in >3700-Ma sea-floor sedimentary rocks from west
greenland. Science. 283:674–676. 1999.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dodd MS, Papineau D, Grenne T, Slack JF,
Rittner M, Pirajno F, O'Neil J and Little CT: Evidence for early
life in Earth's oldest hydrothermal vent precipitates. Nature.
543:60–64. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Knoll AH, Javaux EJ, Hewitt D and Cohen P:
Eukaryotic organisms in Proterozoic oceans. Philos Trans R Soc Lond
B Biol Sci. 361:1023–1038. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fedonkin MA: The origin of the Metazoa in
the light of the Proterozoic fossil record. Paleontol Res. 7:9–41.
2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Barrangou R: The roles of CRISPR-Cas
systems in adaptive immunity and beyond. Curr Opin Immunol.
32:36–41. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Koonin EV and Makarova KS: Mobile genetic
elements and evolution of CRISPR-Cas systems: All the way there and
back. Genome Biol Evol. 9:2812–2825. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature.
391:806–811. 1998.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Elbashir SM, Harborth J, Lendeckel W,
Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs
mediate RNA interference in cultured mammalian cells. Nature.
411:494–498. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Han H: RNA interference to knock down gene
expression. Methods Mol Biol. 1706:293–302. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Abdelrahim M, Safe S, Baker C and
Abudayyeh A: RNAi and cancer: Implications and applications. J RNAi
Gene Silencing. 2:136–145. 2006.PubMed/NCBI
|
|
13
|
Ghildiyal M and Zamore PD: Small silencing
RNAs: An expanding universe. Nat Rev Genet. 10:94–108.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Maillard PV, Ciaudo C, Marchais A, Li Y,
Jay F, Ding SW and Voinnet O: Antiviral RNA interference in
mammalian cells. Science. 342:235–238. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Habibi L and Salmani H: Pivotal impacts of
retrotransposon based invasive RNAs on evolution. Front Microbiol.
8(1957)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wei W, Morrish TA, Alisch RS and Moran JV:
A transient assay reveals that cultured human cells can accommodate
multiple LINE-1 retrotransposition events. Anal Biochem.
284:435–438. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lander ES, Linton LM, Birren B, Nusbaum C,
Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al:
Initial sequencing and analysis of the human genome. Nature.
409:860–921. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Wicker T, Sabot F, Hua-Van A, Bennetzen
JL, Capy P, Chalhoub B, Flavell A, Leroy P, Morgante M, Panaud O,
et al: A unified classification system for eukaryotic transposable
elements. Nat Rev Genet. 8:973–982. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Javdat M and Tamara A: RNA interference:
Antiviral defense mechanism and immune memory. Adv Appl Physiol.
5:24–29. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang L, Richards A, Barrasa MI, Hughes
SH, Young RA and Jaenisch R: Reverse-transcribed SARS-CoV-2 RNA can
integrate into the genome of cultured human cells and can be
expressed in patient-derived tissues. Proc Natl Acad Sci USA.
118(e2105968118)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bitko V and Barik S: Phenotypic silencing
of cytoplasmic genes using sequence-specific double-stranded short
interfering RNA and its application in the reverse genetics of wild
type negative-strand RNA viruses. BMC Microbiol.
1(34)2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Coburn GA and Cullen BR: Potent and
specific inhibition of human immunodeficiency virus type 1
replication by RNA interference. J Virol. 76:9225–9231.
2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
McCaffrey AP, Nakai H, Pandey K, Huang Z,
Salazar FH, Xu H, Wieland SF, Marion PL and Kay MA: Inhibition of
hepatitis B virus in mice by RNA interference. Nat Biotechnol.
21:639–644. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Yokota T, Sakamoto N, Enomoto N, Tanabe Y,
Miyagishi M, Maekawa S, Yi L, Kurosaki M, Taira K, Watanabe M and
Mizusawa H: Inhibition of intracellular hepatitis C virus
replication by synthetic and vector-derived small interfering RNAs.
EMBO Rep. 4:602–608. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Krönke J, Kittler R, Buchholz F, Windisch
MP, Pietschmann T, Bartenschlager R and Frese M: Alternative
approaches for efficient inhibition of hepatitis C virus RNA
replication by small interfering RNAs. J Virol. 78:3436–3446.
2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ge Q, McManus MT, Nguyen T, Shen CH, Sharp
PA, Eisen HN and Chen J: RNA interference of influenza virus
production by directly targeting mRNA for degradation and
indirectly inhibiting all viral RNA transcription. Proc Natl Acad
Sci USA. 100:2718–2723. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
He ML, Zheng B, Peng Y, Peiris JS, Poon
LL, Yuen KY, Lin MC, Kung HF and Guan Y: Inhibition of
SARS-associated coronavirus infection and replication by RNA
interference. JAMA. 290:2665–2666. 2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fujino K, Horie M, Honda T, Merriman DK
and Tomonaga K: Inhibition of Borna disease virus replication by an
endogenous bornavirus-like element in the ground squirrel genome.
Proc Natl Acad Sci USA. 111:13175–13180. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Honda T and Tomonaga K: Endogenous
non-retroviral RNA virus elements evidence a novel type of
antiviral immunity. Mob Genet Elements. 22(e1165785)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Idris A, Davis A, Supramaniam A, Acharya
D, Kelly G, Tayyar Y, West N, Zhang P, McMillan CLD, Soemardy C, et
al: A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.
Mol Ther. 29:2219–2226. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Stetson DB and Medzhitov R: Type I
interferons in host defense. Immunity. 25:373–381. 2006.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Levy DE: Whence interferon? Variety in the
production of interferon in response to viral infection. J Exp Med.
195:15–18. 2002.PubMed/NCBI View Article : Google Scholar
|
|
33
|
de Weerd NA and Nguyen T: The interferons
and their receptors-distribution and regulation. Immunol Cell Biol.
90:483–491. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Houglum JE: Interferon: Mechanisms of
action and clinical value. Clin Pharm. 2:20–28. 1983.PubMed/NCBI
|
|
35
|
McNab F, Mayer-Barber K, Sher A, Wack A
and O'Garra A: Type I interferons in infectious disease. Nat Rev
Immunol. 15:87–103. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Katze MG, He Y and Gale M Jr: Viruses and
interferon: A fight for supremacy. Nat Rev Immunol. 2:675–687.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
37
|
Wu J and Chen ZJ: Innate immune sensing
and signaling of cytosolic nucleic acids. Annu Rev Immunol.
32:461–488. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
van der Veen AG, Maillard PV, Schmidt JM,
Lee SA, Deddouche-Grass S, Borg A, Kjær S, Snijders AP and Reis e
Sousa C: The RIG-I-like receptor LGP2 inhibits Dicer-dependent
processing of long double-stranded RNA and blocks RNA interference
in mammalian cells. EMBO J. 37(e97479)2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Maillard PV, van der Veen AG, Poirier EZ
and Reis e Sousa C: Slicing and dicing viruses: Antiviral RNA
interference in mammals. EMBO J. 38(e100941)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Onomoto K, Onoguchi K and Yoneyama M:
Regulation of RIG-I-like receptor-mediated signaling: Interaction
between host and viral factors. Cell Mol Immunol. 18:539–555.
2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Flesch BK and Neppert J: Functions of the
Fc receptors for immunoglobulin G. J Clin Lab Anal. 14:141–156.
2000.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Duncan AR and Winter G: The binding site
for C1q on IgG. Nature. 332:738–740. 1988.PubMed/NCBI View
Article : Google Scholar
|
|
43
|
Eggenberger J, Blanco-Melo D, Panis M,
Brennand KJ and tenOever BR: Type I interferon response impairs
differentiation potential of pluripotent stem cells. Proc Natl Acad
Sci. 116:1384–1393. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Holtzman J and Lee H: Emerging role of
extracellular vesicles in the respiratory system. Exp Mol Med.
52:887–895. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Geekiyanage H, Rayatpisheh S, Wohlschlegel
JA, Brown R Jr and Ambros V: Extracellular microRNAs in human
circulation are associated with miRISC complexes that are
accessible to anti-AGO2 antibody and can bind target mimic
oligonucleotides. Proc Natl Acad Sci USA. 117:24213–24223.
2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Mevorach D: Opsonization of apoptotic
cells. Implications for uptake and autoimmunity. Ann N Y Acad Sci.
926:226–235. 2000.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hawkes RA: Enhancement of the infectivity
of arboviruses by specific antisera produced in domestic fowls.
Aust J Exp Biol Med Sci. 42:465–482. 1964.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Smatti MK, Al Thani AA and Yassine HM:
Viral-induced enhanced disease illness. Front Microbiol.
9(2991)2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Tirado SM and Yoon KJ: Antibody-dependent
enhancement of virus infection and disease. Viral Immunol.
16:69–86. 2003.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Khandia R, Munjal A, Dhama K, Karthik K,
Tiwari R, Malik YS, Singh RK and Chaicumpa W: Modulation of
dengue/zika virus pathogenicity by antibody-dependent enhancement
and strategies to protect against enhancement in zika virus
infection. Front Immunol. 9(597)2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wan Y, Shang J, Sun S, Tai W, Chen J, Geng
Q, He L, Chen Y, Wu J, Shi Z, et al: Molecular mechanism for
antibody-dependent enhancement of coronavirus entry. J Virol.
94:e02015–19. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Yip MS, Cheung CY, Li PH, Bruzzone R,
Peiris JSM and Jaume M: Investigation of antibody-dependent
enhancement (ADE) of SARS coronavirus infection and its role in
pathogenesis of SARS. BMC Proc. 5 (Suppl 1)(P80)2011.
|
|
53
|
Chen X, Pan Z, Yue S, Yu F, Zhang J, Yang
Y, Li R, Liu B, Yang X, Gao L, et al: Disease severity dictates
SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Signal Transduct Target Ther. 5(180)2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Lo MW, Kemper C and Woodruff TM: COVID-19:
Complement, coagulation, and collateral damage. J Immunol.
205:1488–1495. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Benmoussa A and Provost P: Milk MicroRNAs
in health and disease. Compr Rev Food Sci Food Saf. 18:703–722.
2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Manca S, Upadhyaya B, Mutai E, Desaulniers
AT, Cederberg RA, White BR and Zempleni J: Milk exosomes are
bioavailable and distinct microRNA cargos have unique tissue
distribution patterns. Sci Rep. 8(11321)2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zempleni J: Milk exosomes: Beyond dietary
microRNAs. Genes Nutr. 12(12)2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Soye KJ, Trottier C, Richardson CD, Ward
BJ and Miller WH Jr: RIG-I is required for the inhibition of
measles virus by retinoids. PLoS One. 6(e22323)2011.PubMed/NCBI View Article : Google Scholar
|
|
59
|
D'Souza RM and D'Souza R: Vitamin A for
the treatment of children with measles-a systematic review. J Trop
Pediatr. 48:323–327. 2002.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Huiming Y, Chaomin W and Meng M: Vitamin A
for treating measles in children. Cochrane Database Syst Rev.
2005(CD001479)2005.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Paro S, Imler JL and Meignin C: Sensing
viral RNAs by Dicer/RIG-I like ATPases across species. Curr Opin
Immunol. 32:106–113. 2015.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Laudadio I, Orso F, Azzalin G, Calabrò C,
Berardinelli F, Coluzzi E, Gioiosa S, Taverna D, Sgura A, Carissimi
C and Fulci V: AGO2 promotes telomerase activity and interaction
between the telomerase components TERT and TERC. EMBO Rep.
20(e45969)2019.PubMed/NCBI View Article : Google Scholar
|
